• Karachi, Pakistan

The Searle Company Limited - SEARL

Company Details

Sector PHARMACEUTICALS
Address One IBL Centre 2nd Floor Plot # 1 Block 7 & 8 D.M.C.H.S Tipu Sultan Road Off Shahrah-e-Faisal Karachi
Auditor A. F. Ferguson & Co. Chartered Accountants
Registrar CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi
Website www.searlecompany.com
Fiscal Year June
Details

Details

The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993@ the Company was converted into a public limited company under the repealed Companies Ordinance@ 1984 (now Companies Act@ 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company@ which holds 56.32% shareholding in the Company.

Company Announcements

Date/Time Announcement
28/02/2020   15:32:29 (CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,133.146
EPS = 5.24
(CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,622.058
FINANCIAL RESULT FOR THE HALF YEAR ENDED 31/12/2019
28/02/2020   15:32:00 (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,512.803
FINANCIAL RESULT FOR THE HALF YEAR ENDED 31/12/2019
EPS = 5.44
(UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,155.130
29/10/2019   11:16:48 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 30/09/2019
(CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 819.209
(CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 554.616
EPS = 2.57
29/10/2019   11:15:09 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 30/09/2019
(UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 724.361
(UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 547.317
EPS = 2.58
01/10/2019   11:21:56 EPS = 10.55
(CONSOLDIATE) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 2,265.296
(CONSOLDIATE) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 2,832.228
FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2019

Last 30 Days Performance